Huang SM - Search Results

1

Using Machine Learning to Determine a Suitable Patient Population for Anakinra for the Treatment of COVID-19 Under the Emergency Use Authorization.

Liu Q, Nair R, Huang R, Zhu H, Anderson A, Belen O, Tran V, Chiu R, Higgins K, Chen J, He L, Doddapaneni S, Huang SM, Nikolov NP, Zineh I. Liu Q, et al. Among authors: huang r, huang sm. Clin Pharmacol Ther. 2024 Apr;115(4):890-895. doi: 10.1002/cpt.3191. Epub 2024 Feb 13. Clin Pharmacol Ther. 2024. PMID: 38348530

2

Population pharmacokinetics. A regulatory perspective.

Sun H, Fadiran EO, Jones CD, Lesko L, Huang SM, Higgins K, Hu C, Machado S, Maldonado S, Williams R, Hossain M, Ette EI. Sun H, et al. Among authors: huang sm. Clin Pharmacokinet. 1999 Jul;37(1):41-58. doi: 10.2165/00003088-199937010-00003. Clin Pharmacokinet. 1999. PMID: 10451782 Review.

3

Biomarkers in drug development and regulation: a paradigm for clinical implementation of personalized medicine.

Zineh I, Huang SM. Zineh I, et al. Among authors: huang sm. Biomark Med. 2011 Dec;5(6):705-13. doi: 10.2217/bmm.11.90. Biomark Med. 2011. PMID: 22103607 Review.

4

The utility of modeling and simulation in drug development and regulatory review.

Huang SM, Abernethy DR, Wang Y, Zhao P, Zineh I. Huang SM, et al. J Pharm Sci. 2013 Sep;102(9):2912-23. doi: 10.1002/jps.23570. Epub 2013 May 24. J Pharm Sci. 2013. PMID: 23712632 Review.

5

Physiologically based pharmacokinetic modeling: from regulatory science to regulatory policy.

Sinha V, Zhao P, Huang SM, Zineh I. Sinha V, et al. Among authors: huang sm. Clin Pharmacol Ther. 2014 May;95(5):478-80. doi: 10.1038/clpt.2014.46. Clin Pharmacol Ther. 2014. PMID: 24747236

6

Precision Medicine.

Pacanowski M, Huang SM. Pacanowski M, et al. Among authors: huang sm. Clin Pharmacol Ther. 2016 Feb;99(2):124-9. doi: 10.1002/cpt.296. Clin Pharmacol Ther. 2016. PMID: 26800326 No abstract available.

7

Toward greater insights on pharmacokinetics and exposure-response relationships for therapeutic biologics in oncology drug development.

Wang Y, Booth B, Rahman A, Kim G, Huang SM, Zineh I. Wang Y, et al. Among authors: huang sm. Clin Pharmacol Ther. 2017 May;101(5):582-584. doi: 10.1002/cpt.628. Epub 2017 Mar 15. Clin Pharmacol Ther. 2017. PMID: 28090657 Review.

8

Clinical Drug-Drug Interaction Evaluations to Inform Drug Use and Enable Drug Access.

Rekić D, Reynolds KS, Zhao P, Zhang L, Yoshida K, Sachar M, Piquette Miller M, Huang SM, Zineh I. Rekić D, et al. Among authors: huang sm. J Pharm Sci. 2017 Sep;106(9):2214-2218. doi: 10.1016/j.xphs.2017.04.016. Epub 2017 Apr 21. J Pharm Sci. 2017. PMID: 28435142 Review.

9

Effect of Chronic Kidney Disease on Nonrenal Elimination Pathways: A Systematic Assessment of CYP1A2, CYP2C8, CYP2C9, CYP2C19, and OATP.

Tan ML, Yoshida K, Zhao P, Zhang L, Nolin TD, Piquette-Miller M, Galetin A, Huang SM. Tan ML, et al. Among authors: huang sm. Clin Pharmacol Ther. 2018 May;103(5):854-867. doi: 10.1002/cpt.807. Epub 2017 Oct 9. Clin Pharmacol Ther. 2018. PMID: 28990182 Free PMC article.

10

Pharmacogenomics and adverse drug reactions.

Amur S, Zineh I, Abernethy DR, Huang SM, Lesko LJ. Amur S, et al. Among authors: huang sm. Per Med. 2010 Nov;7(6):633-642. doi: 10.2217/pme.10.63. Per Med. 2010. PMID: 29788561

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,241 results

Search Page